title: [Neurourological signs of chronic cerebral vascular diseases].
abstract: Disorders of urination, along with motor and cognitive disorders, are characteristic of different forms of chronic cerebral vascular diseases (CCVD). Irritation symptoms are more frequent in subcortical arteriosclerotic encephalopathy (SAE) and multi infarct hypertonic encephalopathy (MIHE). Overactive urine bladder syndrome (OUBS) caused by neurogenic detrusive hyperactivity manifests itself in frequent urination, nocturia and imperative enuresis and thus decreases quality of life and results in disability of patents with CCVD. At the same time, the character of symptoms points indirectly to the localization of lacunar infarction or the extent of severity of leukoareosis. It is the most frequent form of disorders of urination in the first years of disease that significantly aggravates its course and needs timed diagnosis and pharmacological treatment. Competitive antagonists of muscarinic receptors M2, M3 subtypes are the most effective drugs for treatment of OUBS comorbid to CCVD.
authors.forename: P G
authors.initials: PG
authors.lastname: Shvarts
authors.forename: V V
authors.initials: VV
authors.lastname: Dutov
authors.forename: A S
authors.initials: AS
authors.lastname: Kadykov
authors.forename: V V
authors.initials: VV
authors.lastname: Shvedkov
authors.forename: S V
authors.initials: SV
authors.lastname: Popov
authors.forename: A N
authors.initials: AN
authors.lastname: Plotnikov
mesh_terms: D002561:Cerebrovascular Disorders / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D002908:Chronic Disease; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D011379:Prognosis; D053201:Urinary Bladder, Overactive / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D014554:Urination
chemical_list: D018727:Muscarinic Antagonists